Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| PASI (Psoriāzes laukuma un smaguma indekss)× | SCORAD indekss (SCORing Atopic Dermatitis)× | |
|---|---|---|
| Nozare | Dermatoloģija | Dermatoloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1978 | 1993 |
| Autors≠ | Fredriksson T, Pettersson U | European Task Force on Atopic Dermatitis (ETFAD) |
| Tips | Clinician-rated | Clinician-rated |
| Pirmavots≠ | Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-244. DOI ↗ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ |
| Citi nosaukumi | PASI Index | SCORAD Index |
| Saistītās≠ | 2 | 3 |
| Kopsavilkums≠ | The PASI is the gold-standard clinician-administered measure of psoriasis severity and extent. Developed by Fredriksson and Pettersson in 1978, it evaluates four cardinal clinical signs (erythema, induration, desquamation) across four body regions, each weighted by anatomical importance. PASI is the most widely used endpoint in psoriasis clinical trials and is endorsed by regulatory agencies (FDA, EMA) and international dermatology societies. | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. |
| ScholarGateDatu kopa ↗ |
|
|